Categories:Corporate

PowderJect Pharmaceuticals completes vendor placing of shares and acquisition of SBL Vaccin from Active Biotech for £35.5m, 75 per cent of which came from the placing.

  • Print
  • Comment

Have your say

Mandatory Required Fields

  • Print
  • Comment